ugli
fact
signific
amount
world
popul
contract
sarscov
infect
current
spread
specif
treatment
yet
come
soon
individu
risk
assess
manag
strategi
crucial
individu
prevent
protect
measur
drive
person
risk
get
diseas
among
viruscontract
host
differ
metabol
statu
determin
diet
nutrit
age
sex
medic
condit
lifestyl
environment
factor
govern
person
fate
toward
differ
clinic
sever
asymptomat
mild
moder
death
care
individu
assess
possibl
dietari
nutrit
medic
lifestyl
environment
risk
togeth
proper
relev
risk
manag
strategi
sensibl
way
deal
pandem
sarscovii
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
thirdknown
zoonot
diseas
coronaviru
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
sarscovii
belong
famili
coronavirida
genu
betacoronaviru
includ
sarscov
merscov
current
data
suggest
mortal
rate
substanti
lower
mortal
rate
sar
mer
respect
howev
concern
high
transmiss
sarscovii
basic
reproduct
number
r
make
rapidli
spread
diseas
compar
r
sarscov
merscov
less
respect
viral
genom
analysi
suggest
sarscovii
recombin
viru
bat
coronaviru
unidentifiedorigin
coronaviru
human
transmiss
presum
anim
still
inconclus
whether
anim
origin
human
transmiss
chain
bat
snake
other
howev
posit
viru
find
environment
sampl
seafood
industri
seafood
market
respiratori
droplet
cough
sneez
primari
medium
humantohuman
transmiss
frequent
symptom
respiratori
ill
ie
fever
higher
patient
cough
fit
patient
final
sever
fatigu
myalgia
patient
report
sever
patient
dyspnea
patient
appear
eight
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
day
first
sever
complic
diseas
howev
headach
diarrhea
hemoptysi
dyspnea
report
clinic
manifest
studi
china
also
report
major
patient
consid
mild
pneumonia
asymptomat
pose
big
challeng
spread
close
contact
infect
individu
either
asymptomat
clinic
case
increas
risk
infect
monitor
cluster
case
china
suggest
possibl
indirect
viral
transmiss
without
histori
close
physic
connect
infect
individu
viral
transfer
possibl
common
contamin
object
viral
aerosol
confin
space
asymptomat
viral
carrier
gener
prevent
guidelin
includ
frequent
hand
wash
mouth
nose
cover
cough
sneez
cook
social
distanc
help
avoid
close
contact
symptomat
asymptomat
individu
rapid
identif
case
detect
isol
treatment
contain
public
spread
sarscovii
host
metabol
condit
also
determin
clinic
cours
outcom
specif
treatment
case
manag
support
symptomat
measur
global
pandem
spread
us
may
get
sarscovii
infect
certain
period
therefor
individu
action
minim
infect
risk
modul
sever
clinic
cours
crucial
amidst
public
healthcar
measur
figur
repres
conceptu
framework
articl
review
person
prevent
measur
predispos
host
factor
potenti
therapeut
option
suggest
comprehens
approach
manag
sarscovii
remain
viabl
aerosol
three
hour
live
differ
surfac
materi
three
day
polypropylen
plastic
coupl
day
stainless
steel
twentyfour
hour
cardboard
four
hour
copper
increas
temperatur
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
humid
reduc
transmiss
certain
degre
surfac
disinfect
includ
ethanol
hydrogen
peroxid
sodium
hypochlorit
effici
inactiv
sarscovii
within
one
minut
contrast
biocid
agent
benzalkonium
chlorid
chlorhexidin
diglucon
less
effect
avoid
contamin
medium
therefor
critic
prevent
measur
togeth
social
distanc
possibl
infect
individu
person
hygien
could
reduc
individu
exposur
sarscovii
contamin
surfac
measur
includ
regular
hand
wash
particularli
sneez
cough
exposur
public
washroom
meal
prepar
regular
clean
publictouch
surfac
common
tool
utensil
disinfect
also
necessari
avoid
face
eye
nose
mouth
touch
reduc
introduct
contamin
hand
respiratori
mucos
surfac
social
distanc
prevent
contact
aerosol
droplet
infect
individu
asymptomat
carrier
face
mask
may
necessari
healthi
person
facecov
provid
sens
protect
peopl
inappropri
use
dispos
mask
may
increas
infect
risk
henc
recommend
use
face
mask
individu
symptom
quarantin
spread
sarscovii
one
reduc
viral
contract
risk
prevent
measur
report
china
itali
suggest
high
mortal
rate
older
male
patient
multipl
metabol
comorbid
host
metabol
statu
influenc
age
sex
medic
condit
lifestyl
factor
cigarett
smoke
determin
clinic
sever
new
studi
refin
knowledg
symptom
caus
epidem
affect
world
popul
also
highlight
presenc
aggrav
factor
sever
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
case
look
critic
ill
patient
two
preval
ill
appear
worsen
infect
first
hypertens
sinc
patient
critic
condit
suffer
second
posit
come
diabet
without
distinct
type
made
affect
sever
case
moreov
comorbid
coronari
heart
diseas
cerebrovascular
diseas
report
sever
case
bad
lifestyl
habit
smoke
also
play
role
infect
patient
nonsmok
sever
case
declar
use
tobacco
compar
less
sever
case
coexist
metabol
diseas
includ
type
diabet
hypertens
heart
diseas
histori
stroke
cancer
therefor
host
predispos
factor
significantli
determin
ill
cours
progress
outcom
elder
prone
infect
includ
respiratori
diseas
young
peopl
accompani
increas
mortal
rate
agerel
immunolog
chang
probabl
result
primari
secondari
structur
function
chang
bone
marrow
thymu
lymphoid
organ
immun
cell
despit
multifacet
process
age
elder
commonli
decreas
abil
fight
infect
diminish
respons
vaccin
increas
preval
autoimmun
constitut
lowgrad
inflamm
conform
fact
mortal
rate
increas
older
adult
clinic
set
studi
blood
mononuclear
cell
suggest
epigenom
signatur
declin
cell
increas
monocyt
cytotox
cell
function
higher
male
femal
elder
agerel
immunolog
chang
sex
differ
first
occur
around
age
latethirti
secondbiggest
spike
age
sixtyf
older
man
prone
infecti
diseas
high
proinflammatori
immun
respons
low
adapt
immun
respons
older
woman
case
china
itali
report
higher
fatal
male
women
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
metabolit
clostridium
orbiscindensderiv
desaminotyrosin
certain
strain
lactobacillu
also
influenc
ifn
respons
follow
influenza
infect
host
dietari
pattern
pivot
determin
gut
microbiota
commun
structur
function
gener
balanc
diet
variat
prebiot
fiber
probiot
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
polyphenol
promot
healthi
divers
microbiota
improv
diet
qualiti
suscept
individu
might
allevi
risk
sever
infect
despit
inconclus
piec
evid
oral
probiot
expect
ration
adjunct
option
variou
viral
diseas
manag
diet
nutrit
invari
influenc
immun
system
compet
determin
risk
sever
infect
bidirect
relationship
among
diet
nutrit
infect
immun
chang
one
compon
impact
other
macro
micronutri
phytonutri
diet
mainli
fruit
color
veget
gener
promot
healthi
immun
respons
microand
phytonutri
provid
antioxid
antiinflammatori
nutrient
includ
betacaroten
vitamin
c
vitamin
e
polyphenol
compound
modul
immun
function
antiinflammatori
strategi
either
food
nutrient
medicin
viabl
option
manag
apart
agerel
micronutri
insuffici
previous
mention
nutrit
statu
individu
affect
risk
sarscovii
infect
clinic
cours
outcom
therefor
mainten
host
macroand
micronutri
statu
import
prevent
measur
numer
micronutri
essenti
immunocompet
particularli
vitamin
c
e
bs
iron
selenium
zinc
dietari
pattern
vital
maintain
individu
nutrit
statu
howev
diet
alon
may
suffici
certain
metabol
lifestyl
condit
includ
advanc
age
coexist
medic
condit
cigarett
smoke
occup
exposur
environment
toxin
herein
review
micronutri
requir
attent
risk
reduct
clinic
cours
modul
vitamin
sever
metaanalysi
systemat
review
support
protect
role
vitamin
supplement
prevent
acut
respiratori
tract
infect
effect
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
iud
vitamin
week
rapidli
rais
oh
concentr
follow
iud
vitamin
despit
establish
role
vitamin
support
immun
function
inadequ
evid
support
supplement
benefit
healthi
individu
prevent
acut
viral
respiratori
infect
howev
vitamin
defici
peopl
prone
increas
risk
high
sever
impair
immun
respons
viral
infect
includ
respiratori
syncyti
viru
measl
viru
influenza
viru
immunesupport
role
vitamin
includ
promot
mucin
keratin
lymphopoiesi
apoptosi
cytokin
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
decemb
sever
unidentifi
pneumonia
case
occur
wuhan
china
januari
led
world
health
organ
declar
public
health
emerg
intern
concern
march
declar
outbreak
novel
coronaviru
global
pandem
suggest
offici
name
diseas
viru
coronaviru
diseas
coronavirida
studi
group
intern
committe
taxonomi
virus
propos
name
viru
sever
acut
respiratori
syndrom
coronaviru
sarscovii
design
phylogeni
taxonomi
april
regist
confirm
case
death
worldwid
connect
age
diet
nutrient
immun
elder
clinic
subclin
micronutri
defici
common
older
adult
contribut
sever
agerel
diseas
decreas
immun
function
preval
probabl
consequ
low
appetit
natur
littl
diversif
dietari
pattern
elder
nutrit
assess
proper
manag
therefor
essenti
determin
risk
infect
ill
cours
outcom
older
adult
divers
intestin
microbiota
shape
immun
system
promot
host
wellb
respiratori
tract
microbiota
also
influenc
host
immun
respons
viru
immun
respons
viral
infect
determin
efficaci
vaccin
disrupt
gut
microbiota
contribut
vaccin
failur
inflammatori
condit
acut
respiratori
viral
infect
disrupt
hostmicrobiota
interact
creat
intestin
dysbiosi
postvir
immun
respons
contribut
pneumonia
develop
secondari
bacteri
infect
healthi
divers
intestin
respiratori
tract
microbiota
anoth
critic
determin
clinic
cours
interferon
ifn
first
line
immun
defens
viral
infect
particularli
type
ifn
type
iii
ifn
despit
preliminari
understand
role
probabl
critic
antivir
cytokin
respiratori
epitheli
surfac
earli
stage
viral
infect
type
ifn
signal
acut
viral
infect
increas
proinflammatori
respons
signal
persist
infect
modul
counterregulatori
immun
respons
gut
microbiom
mediat
ifn
respons
viral
infect
supplement
need
start
onset
respiratori
tract
infect
howev
inconclus
evid
regard
underli
mechan
vitamin
defici
viral
diseas
develop
potenti
mechan
includ
antivir
immun
induct
modul
immunoregulatori
defens
induct
autophagi
apoptosi
genet
epigenet
regul
furthermor
risk
viral
infect
reduc
vitamin
relat
mechan
compris
stimul
defensin
cathelicidin
decreas
replic
viru
increas
level
antiinflammatori
cytokin
well
decreas
concentr
proinflammatori
cytokin
induc
inflammationrel
pneumonia
support
data
effect
role
vitamin
decreas
risk
could
highlight
increas
casefat
rate
chronic
diseas
comorbid
age
lower
concentr
oh
report
vitamin
defici
global
preval
particularli
elder
half
hospit
elder
nurs
home
resid
us
vitamin
defici
high
preval
probabl
contribut
first
outbreak
winter
high
mortal
rate
older
adult
natur
sourc
vitamin
sunlight
exposur
dietari
sourc
provid
certain
amount
vitamin
includ
fortifi
cereal
milk
howev
peopl
risk
goal
rais
concentr
oh
ngml
nmoll
consid
take
express
antibodi
product
enhanc
function
neutrophil
natur
killer
cell
monocyt
macrophag
cell
b
cell
vitamin
c
defici
associ
pneumonia
sever
piec
literatur
earli
day
immunemodul
effect
respiratori
infect
vitamin
c
also
welldocu
nevertheless
support
evid
vitamin
c
supplement
prevent
treatment
acut
respiratori
diseas
inconclus
align
evid
micronutri
supplement
could
benefit
vitamin
c
defici
individu
healthi
subject
moreov
report
megados
administr
vitamin
c
appear
flu
symptom
could
prevent
reliev
flu
symptom
test
popul
regard
control
group
base
studi
comparison
common
cold
episod
reveal
regular
supplement
vitamin
c
modest
consist
effect
decreas
durat
common
cold
symptom
furthermor
five
trial
particip
show
vitamin
c
decreas
risk
common
cold
without
advers
effect
vitamin
c
supplement
thu
sensibl
option
prevent
support
immun
respons
micronutrientdeficit
individu
risk
integr
part
sever
selenoprotein
includ
glutathion
peroxidas
thioredoxin
reductas
selenium
critic
role
defens
viral
infect
antioxid
redox
signal
redox
homeostat
contribut
selenium
defici
associ
increas
pathogen
sever
viru
infect
defici
state
selenium
supplement
help
prevent
treatment
viral
infect
recent
report
mild
strain
influenza
viru
also
show
increas
virul
seleniumdefici
mice
increas
virul
relat
sever
modif
viral
genom
furthermor
immun
respons
proinflammatori
chemokin
increas
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
seleniumdefici
mice
moreov
mrna
express
macrophag
inflammatori
monocyt
chemotact
rant
regul
upon
activ
normal
cell
express
secret
chang
seleniumdefici
mice
mrna
level
cytokin
also
modifi
seleniumdefici
mice
increas
wherea
interleukin
il
decreas
suggest
modif
toward
pattern
sedefici
mice
regard
pattern
seadequ
mice
therefor
selenium
intak
differenti
affect
numer
type
immun
respons
relat
mechan
reveal
effect
role
seleniumsupplement
viral
diseas
zinc
essenti
micronutri
crucial
contribut
enzymat
function
transcript
regul
human
bodi
zinc
essenti
normal
function
develop
cell
regul
nonspecif
immun
includ
natur
killer
cell
neutrophil
zinc
main
structur
compon
around
zincfing
transcript
factor
defici
zinc
also
modifi
develop
acquir
immun
limit
certain
outgrowth
function
lymphocyt
includ
product
activ
cytokin
function
macrophag
also
advers
affect
defici
zinc
dysregul
cytokin
product
intracellular
kill
phagocytosi
zinc
defici
surprisingli
common
modernday
lifestyl
zinc
defici
impair
antivir
immun
particularli
herp
simplex
common
cold
herp
simplex
viru
hepat
c
human
immunodefici
viru
hiv
metaanalysi
oral
zinc
supplement
studi
suggest
benefici
effect
shorten
symptom
durat
common
cold
infect
zinc
supplement
also
help
hepat
c
viru
infect
induct
metallothionein
express
moreov
research
shown
zinc
antivir
effect
improv
immun
respons
suppress
viral
replic
therefor
consumpt
mg
zinc
per
day
may
provid
protect
role
pandem
like
improv
host
resist
viral
infect
howev
studi
account
underli
zinc
statu
studi
particip
yet
specif
treatment
therefor
physician
tri
fight
coronaviru
exist
treatment
patient
admit
hospit
administ
intraven
antibiot
case
prescrib
oseltamivir
oral
antivir
case
corticosteroid
case
protocol
accompani
oxygen
therapi
noninvas
ventil
sever
affect
patient
even
prevent
protect
measur
still
chanc
get
sarscovii
infect
without
specif
treatment
explor
potenti
therapeut
option
prescrib
medic
herb
antivir
medic
target
sever
compon
sarscovii
lifecycl
molecular
target
includ
viral
entri
host
cell
viral
rna
synthesi
viral
replic
high
sequenc
similar
genom
sarscovii
sarscov
merscov
possibl
share
effect
previous
approv
medic
condit
treatment
viral
entri
blockag
includ
chloroquin
hydroxychloroquin
umifenovir
interferon
cell
line
studi
report
chloroquin
significantli
decreas
human
replic
lower
concentr
clinic
dosag
systemat
review
suggest
rational
preclin
support
evid
effect
sarscovii
clinic
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
safeti
profil
justifi
futur
clinic
research
chloroquin
hydroxychloroquin
patient
current
sever
clinic
trial
chloroquin
either
monotherapi
combin
medic
azithromycin
nonrandom
clinic
trial
report
reduct
viral
load
hydroxychloroquineazithromycin
combin
twenti
patient
fail
report
critic
clinic
outcom
includ
death
chloroquin
hydroxychloroquin
immunomodulatori
drug
potenti
antivir
effect
howev
longknown
clinic
sideeffect
interact
medic
still
prematur
conclud
role
chloroquin
hydroxychloroquin
sever
clinic
trial
way
sarscov
ii
enter
target
cell
angiotensinconvert
enzym
receptor
transmembran
proteas
serin
inhibitor
block
cellular
entri
sarscovii
viru
downregul
prime
sarscovii
spike
protein
known
inhibitor
market
ie
camostat
mesyl
machin
learn
algorithm
entri
pathway
reveal
mechanist
possibl
includ
janusassoci
kinas
inhibitor
baricitinib
ruiolitinib
imatinib
drug
current
clinic
trial
medic
inhibit
viral
rna
synthesi
includ
remdesivir
favipiravir
ribavirin
remdesivir
novel
nucleotid
analog
broadspectrum
antivir
activ
singl
proofread
exoribonucleas
hamper
effect
nucleotidebas
antivir
treatment
remdesivir
inhibit
coronaviru
intact
proofread
thu
render
superior
antivir
efficaci
experiment
treatment
intraven
remdesivir
first
patient
us
show
impress
respons
current
random
placebocontrol
doubleblind
multicent
phase
iii
clinic
trial
determin
efficaci
safeti
remdesivir
favilavir
guanin
analog
broadspectrum
antivir
activ
select
inhibit
viral
rnadepend
rna
polymeras
favilavir
efficaci
variou
rna
virus
includ
influenza
ebola
yellow
fever
chikungunya
noroviru
enteroviru
recent
cell
line
studi
suggest
efficaci
sarscovii
got
approv
novel
influenza
treatment
favipiravir
current
clinic
trial
treatment
nation
infecti
diseas
scientif
scienc
research
center
shenzhen
third
peopl
hospit
preliminari
result
eighti
patient
report
superior
efficaci
favipiravir
lopinavirritonavir
combin
without
signific
advers
reaction
medic
block
viru
replic
includ
lopinavirritonavir
combin
darunavircobicistat
combin
lopinavirritonavir
combin
fixeddos
medic
prevent
treatment
hiv
infect
cytochrom
inhibitori
effect
ritonavir
prolong
halflif
lopinavir
extend
proteas
inhibitori
action
hiv
replic
invitro
studi
suggest
lopinavirritonavir
combin
inhibit
coronaviru
replic
j
u
r
n
l
p
r
e
p
r
f
chines
herb
cinanserin
serotonin
receptor
antagonist
may
inhibit
pro
inhibit
sarscov
replic
polyphenol
compound
also
exhibit
pro
inhibitori
effect
antioxid
flavonoid
invitro
studi
demonstr
variou
flavonoid
suppress
hepat
c
viru
merscov
sarscov
pro
inhibitori
effect
flavonoid
includ
herbacetin
isobavachalcon
quercetin
helichrysetin
rhoifolin
pectolinarin
upregul
express
pro
pro
inhibitori
herb
sensibl
option
human
convalesc
plasma
recov
patient
anoth
option
manag
passiv
immunoglobulincontain
plasma
provid
immedi
immun
suscept
individu
long
histori
passiv
antibodi
treatment
variou
infect
diseas
beyond
era
antimicrobi
develop
metaanalysi
suggest
benefici
role
earli
administr
convalesc
plasma
mortal
reduct
influenza
epiderm
report
seriou
advers
effect
treatment
convalesc
plasma
patient
recov
viral
infect
thu
anoth
ration
option
manag
monoclon
antibodi
wellrecogn
passiv
immunotherapeut
option
mani
diseas
humanmad
antibodi
specif
bind
design
target
thu
involv
molecular
mechan
provid
desir
effect
either
inhibit
enhanc
molecular
pathway
updat
knowledg
sarscovii
molecular
mechan
sever
studi
monoclon
antibodi
trial
conduct
mani
pharmaceut
compani
previous
approv
drug
condit
sever
novel
j
u
r
n
l
p
r
e
p
r
f
journal
preproof
drug
target
variou
molecular
target
sarscov
ii
infect
promis
therapeut
outcom
manag
soon
clinic
trial
includ
monoclon
antibodi
target
pathogen
pathophysiolog
process
trial
compris
tocilizumab
target
receptor
possibl
mediat
sarscov
iimedi
inflamm
modul
cytokin
storm
sever
neutral
monoclon
antibodi
target
sarscov
merscov
molecular
mechan
sever
compani
research
group
initi
develop
potenti
vaccin
compani
includ
pfizer
glaxosmithklin
johnson
johnson
mani
other
howev
trial
still
earli
stage
requir
certain
period
potenti
clinic
launch
anticip
option
come
soon
great
tragedi
ugli
fact
lot
world
popul
contract
sarscov
infect
